|
|
|
Cambridge, MA, June 30, 2009 - Novartis Vaccines and Diagnostics received feedback from the US Food and Drug Administration (FDA) in the form of an initial regulatory determination on the Biologics License Application (BLA) for the investigational vaccine Menveo. For those who survive, as many as 19% suffer serious long-term consequences such as deafness, neurological damage or limb loss. Chiron, the blood testing business, is dedicated to preventing the spread of infectious diseases through the development of novel blood-screening tools that protect the world's blood supply.] Centers for Disease Control and Prevention. Available at: http://www.gov/vaccines/pubs/pinkbook/default.
In addition to the statistically significant (P< 0. McManus, President and Chief Executive Officer of Aeolus Pharmaceuticals, Inc.
The statements in this press release that are not purely statements of historical fact are forward-looking statements.
ixing lexapro with xanax 2006 chat gastenboek hotmail site xanax discontinuing xanax xanax no presciption xanax withdraw symptoms
In the US, the prevalence of serogroup Y has increased over the last few years (from 9% of reported cases in 1990-92 to 39% in 2006)[3].] Centers for Disease Control and Prevention.D. Ph. Specific data related to this study will be presented by Dr. AEOL 10150 also demonstrated statistically significant reductions in markers for oxidative stress and inflammation – secondary endpoints for the study. Doses in the range of 5 to 10 mg/kg/d showed a more potent effect including more significant mitigation as assessed by histopathology and immunohistochemistry.
AEOL 10150 offers several unique advantages as a countermeasure for the treatment of ARS, mustard gas and chlorine gas for civilian and military populations. These include:
-- Flexible Treatment Paradigm – AEOL 10150 is intended for the treatment of patients post-exposure, even in those who are already exhibiting symptoms, eliminating the need for immediate administration in a predefined treatment window. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Aeolus' actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements.
|
|
No News has been posted yet
|
|
|
Forgotten your password? Request a new one here.
|
 Guests Online: 1
No Members Online
Registered Members: 1
Unactivated Members: 0
Newest Member: Owen Electrical
|
|
v6.01.1 © 2003-2005